---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-287687"
form_type: "8-K"
ticker: "TNYA"
cik: "0001858848"
company_name: "Tenaya Therapeutics, Inc."
filed_at: "2022-11-17T23:59:59+00:00"
generated_at: "2026-06-21T16:54:11.489519+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Tenaya Therapeutics prices public offering of ~28.85M shares/warrants for ~$75M gross proceeds

## Summary
- Priced public offering of 22,613,307 common shares at $2.60 and 6,236,693 pre-funded warrants at $2.599 per warrant.
- Gross proceeds expected ~$75M before expenses; underwriters have 30-day option for up to 4,327,500 additional shares.
- Offering expected to close Nov 21, 2022; joint book-runners: Morgan Stanley and Piper Sandler.
- Pre-funded warrants have exercise price of $0.001 per share; all securities sold by the company.

## SEC filing metadata
- accession: 0001193125-22-287687
- form_type: 8-K
- ticker: TNYA
- cik: 0001858848
- company_name: Tenaya Therapeutics, Inc.
- filed_at: 2022-11-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1858848/000119312522287687/0001193125-22-287687-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1858848/000119312522287687/d383621d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-287687
- JSON: https://secwatch.observer/filing/0001193125-22-287687.json
- Plain text: https://secwatch.observer/filing/0001193125-22-287687.txt

## Key facts
- Material Agreements
  Tenaya Therapeutics, Inc. entered into Underwriting Agreement with Morgan Stanley & Co. LLC and Piper Sandler & Co., as representatives of the several underwriters named therein valued at approximately $75.0 million (effective 2022-11-16).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: Morgan Stanley & Co. LLC and Piper Sandler & Co., as representatives of the several underwriters named therein
  - Value: approximately $75.0 million
  - Effective: 2022-11-16
  source text: On November 16, 2022, Tenaya Therapeutics, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Morgan Stanley & Co. LLC and Piper Sandler & Co., as representatives (the “Representatives”) of the several underwriters named therein (collectively, the “Underwriters”), relating to the issuance and sale (the “Offering”) of 22,613,307 shares of the Company’s common stock, par value $0.0001 per share, at a price to the public of $2.60 per share (the “Underwritten Shares”) and pre-funded warrants (the “Pre-Funded Warrants”) to purchase 6,236,693 shares of the Company’s common stock at a price to the public of $2.599 per underlying share.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1858848/000119312522287687/0001193125-22-287687-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.